Financial Information

This section houses up-to-date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.

Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. Sera Prognostics assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQSERA
Beta0.94
Shares Outstanding39.2M
Average Volume (10 days)100.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.64)
Sales (TTM)$0.00
Book Value (MRQ)$1.73
Cash Flow (TTM)($0.69)
Cash (MRQ)$0.94

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy4
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Anderson Dyaarl Lee Jr.
Chief Commercial Officer
3,168
Acquire
May 29, 2026
Benjamin Jackson
General Counsel
5,000
Acquire
May 29, 2026
Austin Aerts
Chief Financial Officer
68,550
Acquire
Mar 12, 2026
Anderson Dyaarl Lee Jr.
Chief Commercial Officer
19,310
Acquire
Mar 12, 2026
Inglis Tiffany Eul Davis
Chief Medical Officer
27,034
Acquire
Mar 12, 2026

Recent SEC Filings

Company Events
Jun 4, 2026
Insider Buy/Sell
Jun 4, 2026
Company Events
Jun 1, 2026
DEFA14A
Jun 1, 2026
Insider Buy/Sell
Jun 1, 2026
Email Alerts

Sign up for our investor relations email list here.